IL69927A - Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby - Google Patents

Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby

Info

Publication number
IL69927A
IL69927A IL69927A IL6992783A IL69927A IL 69927 A IL69927 A IL 69927A IL 69927 A IL69927 A IL 69927A IL 6992783 A IL6992783 A IL 6992783A IL 69927 A IL69927 A IL 69927A
Authority
IL
Israel
Prior art keywords
antihemophilic
cryoprecipitate
ahc
pasteurization
prepared
Prior art date
Application number
IL69927A
Other languages
English (en)
Other versions
IL69927A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6175363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL69927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL69927A0 publication Critical patent/IL69927A0/xx
Publication of IL69927A publication Critical patent/IL69927A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Peptides Or Proteins (AREA)
IL69927A 1982-10-09 1983-10-07 Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby IL69927A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823237512 DE3237512A1 (de) 1982-10-09 1982-10-09 Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat

Publications (2)

Publication Number Publication Date
IL69927A0 IL69927A0 (en) 1984-01-31
IL69927A true IL69927A (en) 1987-01-30

Family

ID=6175363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69927A IL69927A (en) 1982-10-09 1983-10-07 Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby

Country Status (10)

Country Link
US (1) US4562072A (fr)
EP (1) EP0106269B2 (fr)
JP (1) JPS5988427A (fr)
AT (1) ATE40646T1 (fr)
CA (1) CA1208131A (fr)
DE (2) DE3237512A1 (fr)
ES (1) ES8405620A1 (fr)
IL (1) IL69927A (fr)
PT (1) PT77464B (fr)
ZA (1) ZA837506B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
US5006642A (en) * 1987-06-29 1991-04-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Purification of von Willebrand Factor by affinity chromatography
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
CA1329760C (fr) * 1987-10-29 1994-05-24 Ted C. K. Lee Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
FR2687317B1 (fr) * 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
AUPO871997A0 (en) * 1997-08-25 1997-09-18 Csl Limited Dried biologically or therapeutically active preparations
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
GB2447685A (en) * 2007-03-21 2008-09-24 Nozotec Ab Haemostatic and dentifrice compositions
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
BR102012015763A2 (pt) * 2012-06-26 2014-12-02 Joel Ligiero Junior Vargas Método para a limpeza de um tanque de armazenamento utilizando skimmer e uso de skimmer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
EP0035204B2 (fr) * 1980-03-05 1991-05-22 Miles Inc. Compositions pasteurisées de protéines thérapeutiquement actives
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x

Also Published As

Publication number Publication date
JPS5988427A (ja) 1984-05-22
EP0106269B2 (fr) 1993-03-10
EP0106269B1 (fr) 1989-02-08
US4562072A (en) 1985-12-31
ZA837506B (en) 1984-06-27
CA1208131A (fr) 1986-07-22
PT77464A (de) 1983-11-01
JPH0348888B2 (fr) 1991-07-25
ES526330A0 (es) 1984-06-16
IL69927A0 (en) 1984-01-31
DE3237512A1 (de) 1984-04-12
PT77464B (de) 1986-04-11
EP0106269A2 (fr) 1984-04-25
ES8405620A1 (es) 1984-06-16
ATE40646T1 (de) 1989-02-15
EP0106269A3 (en) 1985-05-08
DE3379159D1 (en) 1989-03-16

Similar Documents

Publication Publication Date Title
IL69927A (en) Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby
DE3380764D1 (en) Pasteurized human fibrinogen, method of preparing it and its use
ES2032316T3 (es) Procedimiento para la esterilizacion de plasma o fracciones de plasma.
IE900511L (en) Pasteurized, purified von Willebrand factor concentrate and¹a process for the preparation thereof
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
DE3479086D1 (en) Method for the pasteurization of human plasma
DE3478087D1 (en) Method for the pasteurization of plasma or concentrates of blood coagulating factors ii,vii, ix an x
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
AU7408787A (en) A process for the preparation of a pasteurized immunoglobulin preparation
DE69117920D1 (de) Zusammensetzung zur stabilisierung von blutplasma im laufe der pasteurisation

Legal Events

Date Code Title Description
RH Patent void